UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors
    Nancy Sharma
  2. A Randomized, Open-label, Phase II, Multi-center Trial of Gemcitabine (G) with Pazopanib (P) or Gemcitabine (G) with Docetaxel (T) in Previously Treated Subjects with Advanced Soft Tissue Sarcoma
    Mohammed Milhem
  3. A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton's Tyrosine Kinase (BTK) Inh(1)
    Brian Link
  4. A Phase I Pharmacokinetic Study of Intraperitoneal CTEP-Supplied Agent Bortezomib (PS-341, NSC #681239, IND #58443) and Carboplatin (NSC #241240) in Patients with Persistent or Recurrent Ovarian, Fall…
    David Bender
  5. RTOG 1008: A randomized phase II study of adjuvant concurrent radiation and chemotherapy versus radiation alone in resected high-risk malignant salivary gland tumors
    Mark C. Smith
  6. Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
    Ayman El-Sheikh
  7. Study to Investigate Ulcerative Colitis
    Steven Polyak
  8. Study to Determine how Patients with Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer Respond to Treatment
    Mohammed Milhem
  9. Study to Establish Database that will Collect Clinical and Survey Data Outcomes of Head and Neck Squamous Cell Carcinoma
    Nitin Pagedar
  10. Trial for Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
    Ayman El-Sheikh
  11. Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome
    Ayman El-Sheikh
  12. Study of How Women Tolerate Chemotherapy
    David Bender
  13. Effectiveness pf Positron Emission Tomography (PET) Scan on Tumors
    M. Sue O'Dorisio
  14. Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
    Thomas Carter
  15. EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
    Daniel Vaena
  16. Study for Patients with Esophageal or Gastroesophageal Cancer
    Taher Abu Hejleh
  17. Anti-Cancer Activity of Alisertib in Patients with PTCL
    Brian Link
  18. Cell Transplant Study for Multiple Myeloma, POEMS, or Multiple Myeloma with Amyloidosis
    Guido Tricot
  19. Phase 1/2 Study Epigenetic Modification of BRAF-mutated Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine Combined with Vemurafenib
    Mohammed Milhem
  20. A Phase 1, open-label, multi-center, dose escalation study of the safety, tolerability, pharmacodynamic and pharmacokinetic properties of intravenous GC4419 in combination with radiation and chemother…
    John Buatti

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.